Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

80
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
80
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

43
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
43
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

112
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
112
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.4K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.1K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous diseases caused by monoclonal immunoglobulin and/or free light chains (monoclonal gammopathy of cutaneous significance).

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Changes in hemostasis and other disorders caused by monoclonal immunoglobulin and/or free light chains.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Treatment of Castleman disease from the perspective of the year 2026.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Monoclonal gammopathy of clinical significance - a group name for diseases caused by monoclonal immunoglobulin and/ or free light chains. A change in the approach to non-malignant gammopathies.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same author

Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025

Related Experiment Video

Updated: Oct 10, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.6K

Erdheim-Chester disease.

M Brychtová, M Vlachová, J Gregorová

    Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
    |December 16, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Erdheim-Chester disease is a rare histiocytosis marked by foamy histiocyte accumulation and genetic mutations. Understanding its multisystemic nature and molecular drivers aids diagnosis and targeted therapy development.

    Keywords:
    Erdheim-Chester diseasePrognosisheart failurehistiocytosisincidencesurvival

    More Related Videos

    Granulocyte-dependent Autoantibody-induced Skin Blistering
    12:23

    Granulocyte-dependent Autoantibody-induced Skin Blistering

    Published on: October 12, 2012

    10.6K
    Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
    11:12

    Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

    Published on: April 11, 2019

    7.2K

    Related Experiment Videos

    Last Updated: Oct 10, 2025

    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
    10:27

    Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

    Published on: December 15, 2011

    24.6K
    Granulocyte-dependent Autoantibody-induced Skin Blistering
    12:23

    Granulocyte-dependent Autoantibody-induced Skin Blistering

    Published on: October 12, 2012

    10.6K
    Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
    11:12

    Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

    Published on: April 11, 2019

    7.2K

    Area of Science:

    • Oncology
    • Immunology
    • Genetics

    Background:

    • Erdheim-Chester disease is a rare inflammatory myeloid clonal disorder within the histiocytoses.
    • It involves excessive accumulation of foamy histiocytes and Touton giant cells, producing pro-inflammatory mediators.
    • These cells harbor somatic mutations in key signaling pathways, including MAPK/ERK and PI3K/AKT.

    Purpose of the Study:

    • To elucidate the underlying molecular mechanisms of Erdheim-Chester disease.
    • To highlight the diverse clinical manifestations and diagnostic challenges.
    • To outline current therapeutic strategies for this rare condition.

    Main Methods:

    • Review of existing literature on Erdheim-Chester disease.
    • Analysis of cellular characteristics, including histiocyte morphology and cytokine production.
    • Identification of common somatic mutations in affected genes, such as BRAFV600E, MAP2K1, KRAS, NRAS, ARAF, and PIK3CA.

    Main Results:

    • The disease is characterized by foamy histiocytes and Touton giant cells with specific genetic mutations.
    • BRAFV600E is the most frequent mutation, alongside others in MAPK/ERK and PI3K/AKT pathways.
    • Erdheim-Chester disease affects multiple organs, complicating diagnosis due to varied presentations.

    Conclusions:

    • Erdheim-Chester disease is a multisystemic disorder driven by specific genetic mutations.
    • Early diagnosis is crucial, though challenging due to its diverse clinical spectrum.
    • Targeted therapies, including kinase inhibitors and cytokine blockers, offer treatment options.